TNF and Granuloma: TNF further plays a key role in confining mycobacteria to granulomas and achieving a latent state of the disease, which may explain both the timing of disease reactivation,usually observed within the first months of treatment, and the difference between the different TNF antagonist, which display different kinetics leading to different TNF bioavailability in granulomatous tissue [56,57].